New drug trial offers hope for Tough-to-Treat bowel disease
NCT ID NCT07232576
Summary
This study is testing an experimental drug called SHR-1139 in adults with moderate-to-severe ulcerative colitis, a chronic inflammatory bowel disease. It aims to see if the drug can reduce symptoms and improve gut healing over a 60-week period. The trial is for people who haven't gotten enough relief from standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital,Sun Yat-Sen University
RECRUITINGGuangzhou, Guangdong, 510080, China
Contact
Conditions
Explore the condition pages connected to this study.